100% Quality Guarantee
PhD-Level Technical Support
Key Features

PE Anti-Human CD3 Antibody [OKT-3] (AGEL0058)

SKU AGEL0058
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Human
Host Species Mouse
Isotype IgG2a
Clone OKT3
Conjugation PE
Applications FC
$33 - $165

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PE Anti-Human CD3 Antibody [OKT-3]

The PE-Conjugated Human CD3 Monoclonal Antibody (OKT3) is expertly designed for research involving CD3, a crucial cell surface molecule essential for T-cell activation and immune response regulation. This monoclonal antibody, developed in mice, is highly reactive with human samples and validated for use in flow cytometry applications. The phycoerythrin (PE) conjugation ensures bright and stable red fluorescence, enabling precise and reliable detection.CD3 is a vital component of the T-cell receptor (TCR) complex, playing a significant role in initiating and modulating T-cell responses. Its importance in immune regulation makes CD3 a valuable target for research into cancer, autoimmune disorders, and chronic inflammatory conditions.

The PE-Conjugated Human CD3 Monoclonal Antibody (OKT3) is an indispensable tool for researchers aiming to explore T-cell biology and develop therapies that either enhance or suppress immune function.By enabling accurate and sensitive detection of CD3, this antibody supports comprehensive studies of immune response pathways, contributing to the development of novel therapeutic strategies for immune-related diseases. Understanding the activity of CD3 is crucial for creating targeted therapies that harness or modulate immune function, making this antibody a critical asset for advancing research in immunology and cancer.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose